Exercise may benefit colon cancer patients as much as some drugs: Study
- A 2025 study led by Dr. Sara Char at Dana-Farber found exercise benefits colon cancer patients comparably to some drugs.
- This study arose as colorectal cancer rates rise among younger adults, potentially driven by environmental factors beyond genetics.
- The study showed patients in an exercise program had a 28% lower risk of recurrence and an 80% five-year disease-free survival rate.
- Pfizer presented data on Braftovi, a targeted drug combo doubling survival to 30 months versus 15 months with standard treatment.
- These findings indicate lifestyle changes and targeted therapies could enhance treatment, suggesting exercise be an essential treatment component.
249 Articles
249 Articles
"We Were Astounded": New Study Shows Exercise Could Be a Powerful Colon Cancer Cure
Colon cancer has been making headlines recently, with more young people being diagnosed with the disease. But now, a groundbreaking new study is offering hope for patients. In a first-of-its-kind international study, researchers found that colon cancer patients who participated in a three-year exercise coaching program experienced 28% fewer cancer recurrences and were 37% less likely to die from any cause. Experts are saying these findings, whic…
Exercise may stop colon cancer from returning
For Monday, June 2, WGN’s Ben Bradley and Lourdes Daurte have the latest on new medical information, including: More Coverage: WGN's Medical Watch Study suggests exercise reduces the risk of colon cancer returning Exercise may help prevent colon cancer from returning, according to results from a late-phase trial published Sunday, June 1 in the New England Journal of Medicine. The study looked at people who followed an exercise program aft…
Coverage Details
Bias Distribution
- 69% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage